Pancreatic Cancer Research

ResearcherChinese Academy of SciencesActive in the last 2 years

Junjie Deng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5137-8615; OpenAlex author ID A5011644190. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 4

  1. Nano-enabled regulation of DNA damage in tumor cells to enhance neoantigen-based pancreatic cancer immunotherapy. Last author DOI 10.1016/j.biomaterials.2024.122710↗
  2. Activated Natural Killer Cells-Dependent Dendritic Cells Recruitment and Maturation by Responsive Nanogels for Targeting Pancreatic Cancer Immunotherapy. Co-author DOI 10.1002/smll.202203114↗
  3. The anti-dysenteric drug fraxetin enhances anti-tumor efficacy of gemcitabine and suppresses pancreatic cancer development by antagonizing STAT3 activation. Co-author DOI 10.18632/aging.203301↗
  4. The Anti-Dysenteric Drug Fraxetin Enhances Anti-Tumor Efficacy of Gemcitabine and Suppresses Pancreatic Cancer Development by Antagonizing STAT3 Activation Co-author DOI 10.21203/rs.3.rs-125318/v1↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongheng Bai · 3 shared papers, 2020–2024 · strength 0.42
  2. Jilong Wang · 2 shared papers, 2022–2024 · strength 0.35
  3. Yanyi Xiao · 2 shared papers, 2020–2021 · strength 0.23
  4. Hangcheng Guo · 2 shared papers, 2020–2021 · strength 0.23
  5. Hengyue Zhu · 2 shared papers, 2020–2021 · strength 0.23
  6. Yangyang Guo · 2 shared papers, 2020–2021 · strength 0.23
  7. Qiyu Zhang · 2 shared papers, 2020–2021 · strength 0.23
  8. Jianxin Lyu · 1 shared paper, 2022 · strength 0.16
  9. Zhen Wang · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.